Status:
NOT_YET_RECRUITING
Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Radiologically Isolated Syndromes; Multiple Sclerosis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Radiologically Isolated Syndrome (RIS) is the preclinical stage of Multiple Sclerosis (MS). It is the incidental discovery of white matter abnormalities on brain or spinal cord magnetic resonance imag...
Eligibility Criteria
Inclusion
- RIS patients:
- Patients fulfilling the 2023 diagnostic RIS criteria
- Patients with a radiologically isolated syndrome (RIS) identified in local OFSEP databases (French Multiple Sclerosis Observatory)
- MS patients:
- \- Patients with a normal neurological examination fulfilling the McDonald 2017 MS diagnostic criteria
- For both groups:
- \- Patient affiliated to social security
Exclusion
- The presence of motor, visual or cognitive deficits unrelated to MS that may interfere with test performance
- A diagnosis of progressive MS
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT07135752
Start Date
December 1 2025
End Date
December 1 2027
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06000